erdafitinib,cetrelimab
janssen
['cetrelimab', 'erdafitinib', 'norse', 'erda ', 'muc ,(-much)']
rand phii norse of #1l erdafitinib + cetrelimab (pd-1 inh) in fgfr alt cis-ineligible #muc (n=87) shows orr 54.5% (6 crs, 13.6%) vs 44.2% w/erda alone irrespective of pd-l1. enrichment w/fusions in combo? median os 21 mos w/combo and no new safety signals #asco23 
Medical oncologist and researcher in gastrointestinal and genitourinary cancers @CedarsSinai. Hematology/Oncology fellowship @cityofhope